Seehofer Daniel, Schirmeier Anja, Bengmark Stig, Carter Jessica, Koch Martin, Glanemann Matthias, Nüssler Andreas K, Neuhaus Peter, Menger Michael D
Department of General, Visceral, and Transplant Surgery, Charité Campus Virchow, Berlin, Germany.
J Surg Res. 2009 Aug;155(2):195-200. doi: 10.1016/j.jss.2008.09.011. Epub 2008 Oct 10.
Curcumin (Cur) is a nontoxic, hepatoprotective antioxidant. Recent investigations have demonstrated a protective effect of curcumin pretreatment during cold ischemia of hepatocytes, but its impact on liver regeneration per se has not been investigated so far.
Male Sprague-Dawley rats (n = 6 per group) underwent sham operation, 70% partial hepatectomy (PH), or PH with curcumin application (100 mg per kg bodyweight per day) starting 48 h before surgery. Rats were sacrificed 24 h after surgery. Liver regeneration was analyzed by measurement of relative liver weight, mitotic-index, bromo-deoxy-uridine (BrdU)-incorporation and Ki-67 expression.
The relative liver weight 24 h after surgery was similar in the PH groups with and without curcumin treatment. Also, a comparably high number of Ki-67 positive proliferating hepatocytes was detected in both groups. In contrast, the mitotic index in the untreated PH group (83 +/- 20 mitosis/2000 hepatocytes) was significantly higher than in the curcumin treated group (21 +/- 6). The BrdU labeling index was slightly higher in the curcumin treated group with PH (24% +/- 5%) than in the untreated group (16% +/- 2%). The hepatocyte density as marker of cellular hypertrophy was significantly lower in the curcumin group (474 +/- 23) than in the untreated group (609 +/- 22).
Curcumin inhibits cell cycle progression during normal liver regeneration in rats, predominantly at the level of the G2/M transition point. However, the total liver mass and function was not significantly altered. Nevertheless, application of curcumin in conditions of high physiological cell proliferation should be performed with caution.
姜黄素(Cur)是一种无毒的肝脏保护抗氧化剂。最近的研究表明,姜黄素预处理对肝细胞冷缺血有保护作用,但迄今为止,其对肝脏再生本身的影响尚未得到研究。
雄性Sprague-Dawley大鼠(每组n = 6)接受假手术、70%部分肝切除术(PH)或在手术前48小时开始应用姜黄素(每天每千克体重100毫克)的PH手术。术后24小时处死大鼠。通过测量相对肝脏重量、有丝分裂指数、溴脱氧尿苷(BrdU)掺入和Ki-67表达来分析肝脏再生情况。
术后24小时,接受和未接受姜黄素治疗的PH组相对肝脏重量相似。此外,两组均检测到相当数量的Ki-67阳性增殖肝细胞。相比之下,未治疗的PH组有丝分裂指数(83±20个有丝分裂/2000个肝细胞)显著高于姜黄素治疗组(21±6)。姜黄素治疗的PH组BrdU标记指数(24%±5%)略高于未治疗组(16%±2%)。作为细胞肥大标志物的肝细胞密度,姜黄素组(474±23)显著低于未治疗组(609±22)。
姜黄素在大鼠正常肝脏再生过程中抑制细胞周期进程,主要在G2/M转换点水平。然而,肝脏总质量和功能未发生显著改变。尽管如此,在高生理细胞增殖情况下应用姜黄素应谨慎。